Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus

Inclusion Criteria: * Subjects with T2DM (Type 2 Diabetes Mellitus), including newly-diagnosed subjects, who require treatment with Victoza® according to the clinical judgment of their treating physician * Subjects (and/or parents or the subject's legally acceptable representative) who are capable of giving study-specific signed informed consent before any collection of information Exclusion Criteria: * Subjects with a hypersensitivity to Victoza® or to any of the excipients * Subjects who are pregnant, breast feeding or have the intention of becoming pregnant within the study periods * Subjects with personal or family history of medullary thyroid carcinoma (MTC) * Subjects with multiple endocrine neoplasia syndrome type 2 (MEN2)